Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype- and phenotype-guided supplementation of tamoxifen therapy with endoxifen in breast cancer
DRKS00017765Phase 2Completed
- Sponsor
- Bosch
- Start
- Aug 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of z-endoxifen in breast cancer (3 arms), sponsored by Bosch. Started Aug 2019; status: completed.
02
Drugs
z-endoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on DRKS00017765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017765.